Fipronil KRKA 2.5 mg/ml Cutaneous Spray, Solution for Cats and Dogs

Држава: Велика Британија

Језик: Енглески

Извор: VMD (Veterinary Medicines Directorate)

Купи Сада

Активни састојак:

Fipronil

Доступно од:

Krka d.d., Novo Mesto

АТЦ код:

QP53AX15

INN (Међународно име):

Fipronil

Фармацеутски облик:

Cutaneous spray, solution

Тип рецептора:

POM-V - Prescription Only Medicine – Veterinarian

Терапеутска група:

Cats, Dogs

Терапеутска област:

Ectoparasiticide

Статус ауторизације:

Expired

Датум одобрења:

2015-09-30

Карактеристике производа

                                Issued: September 2015
AN: 01274/2014
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE VETERINARY MEDICINAL PRODUCT
Fipronil KRKA 2.5 mg/ml cutaneous spray, solution for cats and dogs
(UK)
Fypryst 2.5 mg/ml cutaneous spray, solution for cats and dogs (CZ)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml contains
ACTIVE SUBSTANCE:
Fipronil 2.5 mg
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Cutaneous spray, solution
Clear, colourless liquid.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cats and dogs.
4.2
INDICATIONS FOR USE,SPECIFYING THE TARGET SPECIES
Treatment of flea (_Ctenocephalides_ spp.) and tick (_Ixodes ricinus_,
_Rhipicephalus _
_sanguineus_) infestations in dogs and cats.
Treatment of biting lice infestations in dogs (_Trichodectes canis_)
and cats (_Felicola _
_subrostratus_).
The product can be used as part of a treatment strategy for the
control of Flea Allergy
Dermatitis (FAD).
Insecticidal efficacy against new infestations with adult fleas
persists for up to 2
months in cats and up to 3 months in dogs, depending on environmental
challenge.
The product has a persistent acaricidal efficacy for up to 4 weeks
against ticks,
depending on the level of environmental challenge.
4.3
CONTRAINDICATIONS
Do not use on sick (systemic diseases, fever) or convalescent animals
Do not use in rabbits, as adverse reactions and even death could
occur.
Do not use in cases of hypersensitivity to the active substance or to
any of the
excipients.
Issued: September 2015
AN: 01274/2014
Page 2 of 7
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
When used as part of a strategy for the treatment of flea allergy
dermatitis, monthly
applications to the allergic patient and to other cats and dogs in the
household are
recommended.
Treatment of bedding, carpets and soft furnishings with a suitable
insecticide will aid
reduction in environmental challenge and maximise the duration of
protection against
re-infestation provided by the product.
The product is not suitable for direct trea
                                
                                Прочитајте комплетан документ
                                
                            

Обавештења о претрази у вези са овим производом